— Know what they know.
Not Investment Advice
Also trades as: ORXOF (OTC) · $vol 0M

ORXOY OTC

Orexo AB (publ)
1W: +0.0% 1M: -37.9% 3M: -45.0% YTD: -57.7% 1Y: -60.0% 3Y: -36.4% 5Y: -79.6%
$1.10
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Strong Sell · Power 36 · $38.6M mcap · 17M float · 0.0013% daily turnover · Short 51% of daily vol

Income Trends

Revenue
$26M -95.6% ▼
5Y CAGR: -47.7%
Gross Profit
-$55M -110.7% ▼
Operating Income
-$346M -146.6% ▼
Net Income
-$129M +36.2% ▲
EPS (Diluted)
$-3.74 +36.5% ▲
EBITDA
-$285M -2293.7% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$565M$624M$639M$590M$26M
YoY Growth-14.9%+10.5%+2.3%-7.6%-95.6%
Cost of Revenue$79M$103M$89M$72M$81M
Gross Profit$486M$522M$550M$518M-$55M
Gross Margin86.0%83.6%86.1%87.8%-213.5%
R&D Expenses$272M$318M$303M$340M$233M
SG&A Expenses$432M$401M$370M$357M$58M
Operating Expenses$711M$736M$659M$658M$291M
Operating Income-$225M-$214M-$110M-$140M-$346M
Operating Margin-39.8%-34.3%-17.1%-23.8%-1334.2%
Interest Expense$28M$28M$41M$60M$50M
Income Before Tax-$222M-$170M-$140M-$191M-$402M
Tax Expense$1M$7M-$12M$12M$299K
Net Income-$224M-$178M-$128M-$203M-$129M
Net Margin-39.6%-28.4%-20.1%-34.4%-499.2%
EPS (Diluted)$-6.51$-5.17$-3.73$-5.89$-3.74
EBITDA-$141M-$74M-$22M$13M-$285M
Shares Outstanding34M34M34M34M35M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms